Gewichtsverlust

Oral Semaglutide Launching in September: New Studies Reveal Risks and Addiction Potential

by

An oral formulation of semaglutide arriving on the pharmaceutical market this coming September is projected to deliver up to 16.6% weight loss in clinical evaluations, according to data reviewed by medical regulators and public health researchers. This upcoming launch marks a significant shift in the delivery of glucagon-like peptide-1 (GLP-1) receptor agonists, moving patients away … Read more

Low-Calorie Diets: Long-Term Weight Loss Results After One Year

by

New evidence regarding long-term weight management suggests that rapid weight loss does not inherently trigger the metabolic “yo-yo effect” often feared by those seeking to reduce body mass. Clinical data indicates that individuals who adopt strict, low-calorie interventions can maintain significant weight reduction over a one-year period, challenging the long-standing medical assumption that faster weight … Read more

New Research Debunks the Yo-Yo Effect in Rapid Weight Loss

by

Scientific research indicates that the “yo-yo effect”—the common belief that rapid weight loss inevitably triggers a metabolic collapse leading to quick weight regain—is not an inevitable physiological response. Recent clinical observations suggest that individual metabolic rates vary significantly, and rapid initial weight loss does not inherently damage long-term metabolic health or guarantee weight regain. For … Read more

Why You’re Not Losing Weight: Retatrutide, Psychology, and the Science of Weight Loss Failure

by

Retatrutide has emerged as a significant development in obesity pharmacotherapy, with clinical observations highlighting its potential to drive substantial weight reduction. As researchers continue to evaluate the efficacy of newer agents in the treatment of metabolic health, the focus remains on biological mechanisms that influence appetite regulation and gastric function. For those navigating the complexities … Read more

Eli Lilly’s Retatrutid Achieves Weight Loss Comparable to Gastric Bypass; EMA Recommends Wegovy Pill Approval

by

The landscape of obesity treatment is undergoing a fundamental transformation as pharmaceutical innovation begins to mirror the clinical outcomes historically reserved for bariatric surgery. As a physician and health journalist, I have followed the evolution of metabolic medicine for over a decade, and the current shift toward highly potent injectable therapies represents a significant milestone … Read more

"Weight Loss Repairs Heart Muscle Cells: Could This Fuel Germany’s Sugar Tax Debate?"

by

Weight Loss as a Key to Heart Health: New Research Reveals Potential for Heart Muscle Repair Berlin, Germany — For decades, physicians have known that excess weight strains the heart, increasing the risk of conditions like hypertension, coronary artery disease, and heart failure. But a groundbreaking new study suggests that weight loss may do more … Read more

Duodenal Mucosal Resurfacing: A Breakthrough in Weight Loss and Metabolic Health with GLP-1 Medications

by

Duodenal mucosal resurfacing (DMR), an investigational endoscopic procedure, has shown promise in helping patients maintain weight loss after discontinuing GLP-1 receptor agonist medications such as Ozempic and Wegovy, according to findings presented at Digestive Disease Week® (DDW) 2026. The minimally invasive technique, which uses hydrothermal ablation to renew the lining of the upper small intestine, … Read more

Melissa McCarthy’s Golden Globes Look: A Stunning Transformation

by

2026-01-13 08:54:00 Die Schauspielerin Melissa McCarthy überrascht bei den Golden Globes 2026 mit einem schlanken Look im hautengen schwarzen Kleid. Bei den Golden Globes 2026 beeindruckt Schauspielerin Melissa McCarthy in einem figurbetonten schwarzen Kleid – keystone Melissa McCarthy (55) hat bei ihrem Auftritt auf dem roten Teppich alle Blicke auf sich gezogen. Die Schauspielerin entschied … Read more

The Yo-Yo Effect: Understanding Weight Cycling & How to Break Free

by

The pursuit of weight loss has led many to explore medications like Ozempic and Wegovy, alongside older options‍ such as Orlistat and Fenfluramin.Increasingly, individuals are turning to these drugs to achieve their desired weight. Recent data from a report released in early 2026 indicates that the use⁣ of weight loss medications‍ in Germany has roughly … Read more